• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Top 50 Companies in Point-of-Care Diagnostic Testing

$2,800.00 – $5,600.00

Clear
SKU: KLI15339039 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Pages: 179
  • Description
  • Table of Contents
  • Latest reports

Description

The POC market is considered evolving with growthopportunity.   Developing and developedmarkets alike have room to grow due to an aging population worldwide.  Key companies such as Roche, LifeScan,Abbott, and Alere will likely maintain leading positions in the market throughcontinued product innovation and strategic alliances and mergers.  This report profiles 50 companies that will determine the future of POC testing, and also provides market sizing and forecast for:

• The Global Point-of-Care Market, 2016-2021
• The Global POC Market by Testing Segment
• Self Testing vs. Professional POC Tests

Market share is also provided for major players in the POC market. Â
Companies covered include:
Abaxis, Inc.
• Abbott Laboratories
• Accriva Diagnostics
• Accubiotech Co, Ltd.
• Acon Laboratories, Inc
• Alere Inc
• Arkray
• Atlas Genetics Ltd.
• Atlas Link Biotech Co., Ltd.
• Beckman Coulter, Inc.
• Bioptix, Inc
• Biomeme, Inc
• Biomerieux SA
• Cepheid
• Chembio Diagnostic Systems, Inc.
• Church & Dwight Co. Inc
• Danaher Corporation

And several other companies…

Table of Contents

1: EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
  • Size and Growth Of The Point-Of-Care Market  
    • Table 1-1: Global POC Test Market, 2014-2021 (In Millions % At Manufacturer Level)
  • Trend – Alere and Abbott Merger
    • Figure 1-1: POC Market Share Pre Alere/Abbott Merger
    • Figure 1-2: POC Market Share Post-Alere/Abbott Merger
  • Trend – “Star Trek” POC Devices
  • Trend – Danaher Buys Cepheid
  • Trend – Retail Clinics
  • Companies In The POC Market

2: TOP 50 POINT OF CARE DIAGNOSTIC COMPANIES – CORPORATE PROFILES

  • Overview
  • Abaxis, Inc.
    • Table 2-1: Abaxis Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-2: Abaxis Revenue (2013-2016) ($ Thousands)
  • Abbott Laboratories
    • Table 2-3: Abbott Corporate Summary
    • Company Overview
    • Product
    • Performance Review
    • Table 2-4: Abbott Laboratories Revenue (2013-2016) ($ Millions)
  • Accriva Diagnostics
    • Table2-5: Accriva Diagnostics Summary
    • Company Overview
    • Products
  • Accubiotech Co, Ltd.
    • Table 2-6: Accubiotech Summary
    • Company Overview
    • Products
  • Acon Laboratories, Inc
    • Table 2-7: Acon Laboratories Corporate Summary
    • Company Overview
    • Products
  • Alere Inc
    • Table 2-8: Alere Corporate Summary
    • Company Overview
    • Product 28
    • Performance Review
    • Table 2-9: Alere Revenue (2013-2016) ($ Thousands)
  • Arkray
    • Table 2-10: Arkay Corporate Summary
    • Company Overview
    • Products
  • Atlas Genetics Ltd.
    • Table 2-11: Atlas Genetics Corporate Summary
    • Company Overview
    • Products
  • Atlas Link Biotech Co., Ltd
    • Table 2-12: Atlas Link Biotech Summary
    • Company Overview
  • Beckman Coulter, Inc
    • Table 2-13: Beckman Coulter Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-14: Beckman Coulter (2013-2016) ($ Millions)
  • Bioptix, Inc
    • Table 2-15: Bioptix Summary
    • Company Overview
  • Biomeme, Inc
    • Table 2-16: Biomeme Corporate Summary
    • Company Overview
  • Biomerieux
    • Table 2-17: Biomerieux Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-18: Biomerieux Revenues (2013-2016) ($ Millions)
  • Cephid
    • Table 2-19: Cephid Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-20: Cephid Revenues (2013-2016) ($ Millions)
  • Chembio Diagnostic Systems, Inc.
    • Table 2-21: Chembio Diagnostic Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-22: Chembio Diagnostics Revenues (2013-2016) ($ Millions)
  • Church & Dwight Co. Inc
    • Table 2-23: Church & Dwight Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-24: Church & Dwight Revenue (2013-2016) ($ Millions)
  • Danaher Corporation
    • Table 2-25: Danaher Corporation Summary
    • Company Overview
  • DexCom, Inc
    • Table 2-26: DexCom Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-27: DexCom Revenue (2013-2016) ($ Millions)
  • Dragerwerk Ag & Co. Kgaa
    • Table 2-28: Dragerwerk Corporate Summary
    • Company Overview
    • Products
    • Company Financials
    • Table 2-29: Drager Revenue (2013-2016) ($ Millions)
  • Eiken Chemical Co Ltd.
    • Table 2-30: Eiken Chemical Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-31: Eiken Chemical Revenue (2013-2016) ($ Millions)
  • EKF Diagnostics Holdings Plc
    • Table 2-32: EKF Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-33: EKF Diagnostics Revenue (2013-2016) ($ Millions)
  • Enigma Diagnostics, Ltd.
    • Table 2-34: Enigma Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Enterix, Inc
    • Table 17-35: Enterix Corporate Summary
    • Company Overview
    • Products
  • Exact Sciences
  • Helena Laboratories
    • Table 2-36: Helena Laboratories Corporate Summary
    • Company Overview
    • Products
  • Hema Diagnostic Systems, Llc
    • Table 2-37: Hema Diagnostics Systems Corporate Summary
    • Company Overview
    • Products
  • Instrumentation Laboratory
    • Table 2-38: Instrumentation Laboratory Corporate Summary
    • Company Overview
    • Products
  • Lifescan, Inc
    • Table 2-39: Lifescan Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-40: Lifescan Revenue (2013-2016) ($ Millions)
  • Mbio Diagnostics, Inc
    • Table 2-41: Mbio Diagnostics Summary
    • Company Overview
  • MedMira, Inc
    • Table 2-42: MedMira Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-43: MedMira Revenue (2013-2016) ($ Millions)
  • Menarini Diagnostics
    • Table 2-44: Menarini Diagnostics Summary
    • Company Overview
    • Products
  • Meridian Bioscience, Inc
    • Table 2-45: Meridian Bioscience Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-46: Meridian Bioscience Revenue (2013-2016) ($ Millions)
  • Micronics, Inc
    • Table 2-47: Micronics Summary
    • Company Overview
  • Nova Biomedical, Corp.
    • Table 2-48: Nova Biomedical Corporate Summary
    • Company Overview
    • Products
  • OPKO Health, Inc
    • Table 2-49: OPKO Health Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-50: OPKO Health Revenue (2013-2016) ($ Millions)
  • Orasure Technologies, Inc.
    • Table 2-51: Orasure Technologies Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-52: Orasure Revenue (2013-2016) ($ Millions)
  • Ortho Clinical Diagnostics
    • Table 2-53: Ortho Clinical Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-54: Ortho Clinical Diagnostics Revenue (2013-2016) ($ Millions)
  • Polymer Technologies, Inc (Pts Diagnostics)
    • Table 2-55: Polymer Technologies Corporate Summary
    • Company Overview
    • Products
  • Quantumdx Group Limited
    • Table 2-56: Quantumdx Group Corporate Summary
    • Company Overview
    • Products
  • Quidel Corporation
    • Table 2-57: Quidel Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-58: Quidel Revenue (2013-2016) ($ Millions)
  • Radiometer Medical A/S
    • Table 2-59: Radiometer Medical Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-60: Radiometer Revenue (2013-2016) ($ Millions)
  • Response Biomedical Corp
    • Table 2-61: Response Biomedical Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-62: Response Biomedical Revenue (2013-2016) ($ Millions)
  • Rheonix, Inc
    • Table 2-63: Rheonix Corporate Summary
    • Company Overview
    • Products
  • Roche Diagnostic Corporation
    • Table 2-64: Roche Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-65: Roche Revenue (2013-2016) ($ Millions)
  • Samsung Healthcare
    • Table 2-66: Samsung Healthcare Corporate Summary
    • Company Overview
    • Products
  • Sekisui Diagnostics
    • Table 2-67: Sekisui Diagnostics Summary
    • Company Overview
    • Products
  • Siemens Healthineers
    • Table 2-68: Siemens Healthineers Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-70: Siemens Healthineers Revenue (2013-2016) ($ Millions)
  • Sysmex Corporation
    • Table 2-71: Sysmex Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-72: Sysmex Revenue (2013-2016) ($ Millions)
  • Trinity Biotech Plc
    • Table 2-73: Trinity Biotech Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 2-74: Trinity Biotech Revenue (2013-2016) ($ Millions)
  • Veredus Laboratories Pte Ltd
    • Table 2-75: Veredus Labs Corporate Summary
    • Company Overview
    • Products
  • Xagenic
    • Table 2-76: Xagenic Corporate Summary
    • Company Overview
    • Products

3: POC TESTING MARKET SHARE AND MARKET ANALYSIS

  • Market Overview
  • Table 3-1: Global POC Test Market, 2014-2021 (In Millions % At Manufacturer Level)
  • Market Analysis By Product Categories
    • Table 3-2: Global POC Testing Market Analysis By Product Category, Professional and Self, 2016 (In Millions $)
  • Market Analysis By Subcategory
    • POC Professional Testing
    • Table 3-3: Global POC Professional Testing Market Analysis By Product Subcategory, 2016 (In Millions$)
    • POC Self-Testing
    • Table 3-4: Global POC Self-Testing Market Analysis By Product Category, 2016 (In Millions$)
  • Competitive Analysis
    • Table 3-8: Global POC Testing Market Revenues and Market Share Of Leading Suppliers, 2016 (Millions $)
    • Figure 3-4: Global POC Testing Market Share By Leading Suppliers

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    $4,500.00 – $9,990.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease

    $1,995.00 – $3,990.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Transplant Matching Molecular Diagnostics MarketWound Care Market and Market Share Analysis (by Application [Skin Ulcer/Burns/Surgery]...
Scroll to top